Crump, Nicholas T. http://orcid.org/0000-0001-9610-6763
Ballabio, Erica
Godfrey, Laura
Thorne, Ross
Repapi, Emmanouela http://orcid.org/0000-0001-8085-0731
Kerry, Jon
Tapia, Marta
Hua, Peng http://orcid.org/0000-0003-3774-5033
Lagerholm, Christoffer
Filippakopoulos, Panagis
Davies, James O. J. http://orcid.org/0000-0002-4108-4357
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N010051/1, MC_UU_12009/6, MC_UU_00016/6)
Article History
Received: 14 December 2019
Accepted: 1 December 2020
First Online: 11 January 2021
Competing interests
: T.A.M. is a founding shareholder of OxStem Oncology (OSO), a subsidiary company of OxStem Ltd. J.O.J.D. is a co-founder of Nucleome Therapeutics Ltd. to which he provides consultancy. All other authors have no competing interests.